跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AB-16
首页
药物
AB-16
AB-16
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMBINATION THERAPY FOR TREATING A TUMOR USING ADC COMPRISING ANTI-CD71 ANTIBODIES AND BH3 MIMETICS
EP 4766400 A1
申请人: INATHERYS
优先权: 2023
EP
WO
3 件公开
Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII
EP 2447284 A1
申请人: LFB BIOTECHNOLOGIES
优先权: 2007
EP
MIXTURE COMPRISING AN ALKYLPOLYGLUCOSIDE, A COSURFACTANT AND A POLYMER ADDITIVE
US 2010144898 A1
申请人: ADAMS JOERG
优先权: 2007
US
Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines
CN 107124870 A
申请人: GENENTECH INC
优先权: 2014
CN
Natural active ingredient extracted and separated from leaves and stems of panax quinuefolium L and application of natural active ingredient
CN 105920064 A
申请人: WEIHAI PINHE BIOLOGICAL SCIENCE & TECH CO LTD
优先权: 2016
CN
种纯天然首乌无患子植物皂角液
CN 105816387 B
申请人: 浙江艾卡医学科技有限公司
优先权: 2016
CN
Traditional Chinese medicine Chinese soapberry fruit extract for treating diarrhea of yak calves
CN 105902664 A
申请人: LIN TIANYANG
优先权: 2016
CN
Medicine for treating femoral head necrosis and preparation method and application thereof
CN 107308214 A
申请人: MIAO ZHIHANG
优先权: 2017
CN
一种降糖降压中药组合物及其制备方法
CN 121221687 A
申请人: 宝恒制药(北京)股份有限公司
优先权: 2025
CN
Anti-recombinant sCD40L murine monoclonal antibody as well as preparation method and application thereof
CN 121824765 A
申请人: UNIV EAST CHINA NORMAL
优先权: 2026
CN
药物
反馈